Regulatory Requirements for Clinical Trials of TPs and Class 2 CTGTPs
Learn the regulatory requirements for clinical trials of Therapeutic Products and Class 2 Cell, Tissue and Gene Therapy Products.
This module on the regulatory requirements for clinical trials of Therapeutic Products and Class 2 Cell, Tissue and Gene Therapy Products covers the following:
Scope of Clinical Trials Regulated Under the Health Products (Clinical Trials) Regulations
Risk-Based Regulation of Clinical Trials
Sponsor and Principal Investigator Responsibilities
Clinical Trials Register
Version date: 28 Jul 2025
(Click here to download the slide deck [PDF, 761 KB] (opens in new tab))

Note: With effect from 1 Nov 2026,
The Innovation Office and Clinical Trials Branch (IOCTB) will be renamed Investigational Medicines and Non-Clinical Assessments Division (IMNAD).
IOCTB Learn will be renamed Clinical Trials Learn. Previously published slides and videos will retain the former names.
